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INTRODUCTION: The materials used for root-end filling and perforation repair are in direct 
contact with live tissues e.g. bone and connective tissue; their effects however, are uncertain. The 
aim of this ex vivo study was to evaluate the osteoblastic secretory activity adjacent to gray and 
white mineral trioxide aggregate (MTA) and Intermediate Restorative Material (IRM).
MATERIALS & METHODS: The studied materials were prepared and placed in 24-wells plate. 
Human MG-63 osteoblasts were introduced to materials after their initial set. The supernatant 
fluid was collected after 1, 3, and 7 days and the level of interleukin-1 was measured by ELISA 
test. A microscopic exam was also performed to assess proliferation and viability of the cells. 
Kruskal-Wallis and Tukey tests were used for analysis.
RESULTS: There were significant higher levels of interleukin-1 in the gray and white MTA
groups compared to IRM group (P<0.05). The difference in interleukin-1 secretion level between 
two mineral trioxide aggregate groups was not significant (P>0.05). Morphologic appearance of 
osteoblasts adjacent to gray and white MTA was similar to normal osteoblasts in all observation 
periods, however cells adjacent to IRM were round, signifying cytotoxicity of the adjacent 
material.
CONCLUSION: Human osteoblasts’ has a favorable biologic response to white and gray MTA 
compared to IRM.
KEYWORDS: Biocompatibility, Human, Osteoblast, Interleukin-1β, IRM cement, Mineral 
trioxide aggregate.
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INTRODUCTION
Approximately 6% of endodontic treatments 
are composed of endodontic apical surgery, 
perforation repair, and apexification treatment 
(1). The materials being used in these 
procedures are in direct contact with living 
tissues such as bone and connective tissue; in 
addition, the success rate of these treatments 
depends on regeneration of tissues. Different 
types of living cells are in direct contact with 
these materials among which fibroblasts, 
osteoblasts and cementoblasts are probably the 
most important ones. Accordingly, the ideal 
material in contact with living tissues should be 
biocompatible if not bioactive, unaffected by 
moisture, easy to manipulate, dimensionally 
stable and able to seal the root canal system (2).
Different dental materials have been introduced 
as root-end fillings including Cavit, composite 
resin, amalgam, glass ionomer cement, gutta-
percha (both cold and injectable), gold foil, 
polycarboxylate cement, polyvinyl cement, 
various zinc oxide and eugenol-based cements 
(e.g. Super EBA and Intermediate Restorative 
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Material (IRM)), mineral trioxide aggregate 
(MTA) and Dentin Bonding Agents (DBAs) (3). 
Even with efforts for introducing an ideal root-
end filling, no material has been manufactured yet 
which includes all the assumed properties (4). 
Comparing MTA, amalgam and Super EBA, 
Baek et al. found that MTA’s had most 
favorable periapical tissue response; this was 
due to cementum formation over MTA surface 
when being used in dog's teeth (5). 
MTA was first introduce by Loma Linda 
University in the 1990s as a root-end filling and 
perforation repair material (6,7). Successful 
long-term results of this material in repairing 
root perforations have been reported (8). MTA 
(ProRoot; Dentsply, Tulsa Dental, OK, USA) is 
a powder consisting of fine hydrophilic 
particles. The main ingredients are tricalcium 
and dicalcium silicates, tri-calcium aluminate, 
tri-calcium oxide and silicate oxide. Bismuth 
oxide has been added as a radiopacifier (9).
It has been reported that MTA consists of 
calcium phosphate (10); however, energy 
dispersive analysis with X-ray could not detect 
the presence of phosphorus (11). The original 
formulation was gray in color and there were 
concerns regarding tooth discoloration (2). 
Recently, white MTA has been introduced 
which minimizes the problem of tooth and soft 
tissue discoloration (12). The difference 
between these two forms of MTA has been 
reported to be in the concentrations of 
aluminum, magnesium, and iron compounds 
(11). White MTA lacks the aluminoferrite 
phase that imparts the gray color (9). Although 
MTA has met most of the requirements of an 
ideal root-end filling material, its handling
properties are less than ideal (10).
Several studies have been performed on root-end 
filling and perforation repair materials (13-16). 
These mainly focused on some characteristics of 
materials including biocompatibility, induction
of hard tissue regeneration, and sealing ability.
Biocompatibility of novel dental materials is 
established by in vivo tests in order to evaluate 
interactions between host and material (17). 
Most studies have been performed on gray MTA
as white MTA is more recent. There is some 
conflicting data on the biocompatibility of gray 
and white MTA. This property has been 
investigated on gray MTA through cell 
expression and growth, subcutaneous and intra-
osseous implantation, and direct contact with 
dental tissues in-vivo (18,19). Gray MTA is
thought to be biocompatible, able to induce 
osteogenesis and cementogenesis, and also 
provide favorable seal for root and furcal 
perforations and apical foramina (20). The most 
commonly used methods for evaluation of cell 
proliferation are scanning electron microscopy 
(SEM) and enzyme assay. Enzyme assay 
measures the metabolic activity of cells which 
grow over materials. 
The main type of cytokine which is involved in 
pulp and periapical tissues inflammatory 
reactions is interleukin-1 (IL-1). This factor can 
influence the repair process positively and 
negatively (29). Therefore, IL-1 is considered as 
an indicator of biological status. In this ex vivo
study we investigated the biological properties 
of gray MTA, white MTA and IRM by 
measuring the level of interleukin-1β secreted by 
human osteoblasts adjacent to the materials.
MATERIALS & METHODS
Cell culture
MG-63 osteoblasts from human osteosarcoma 
were obtained from National Cell Bank of Iran 
(NCBI, Pasteur Institute of Iran, Tehran). The 
cells were cultured in RPMI-1640 supplemented 
with 600µg/mL penicillin G, 300g/mL strepto-
mycin, 5g/mL amphotericin B and 10% fetal 
bovine serum. The plates were incubated at 37ºC 
in an atmosphere of 95% air and 5% carbon 
dioxide for 7 days to achieve confluence. 
Preparation of materials 
The root-end filling materials used in the 
current study were gray and white MTA 
(Dentsply, Tulsa Dental, OK, USA) and IRM 
(Dentsply, Caulk, Milford, USA). The materials 
were mixed according to manufacturer’s
instructions and placed in 24-wells plates 
(Falcon, Meylan Cedaux, France) with the 
thickness of 1mm and a surface area of 
11cm2; the materials were kept at 37°C and 
100% humidity for 24 hours to set completely.
After 6 hours, 4105 MG-63 osteoblast cells 
were added to each well of the cell culture. There
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       Figure1. Light microscopic view of osteoblasts a er 7days,A) gray MTA, B) white MTA, and C) IRM, (mag. ×40)
Figure 2. IL-1 level secreted by human osteoblasts 
adjacent to different experimental materials (pg/mL)
were 45 specimens (five specimens of each 
material for three time periods). After adding 
the osteoblasts, the supernatant fluids were 
collected after one, three and seven days; they 
were stored at -20°C also that the specimens 
were ready for assay.
Cell activity was measured in terms of cell 
secretion as determined by secretion of IL-1
using the Enzyme Linked Immunosorbent Assay 
(ELISA). Proliferation and viability of the cells 
treated by test materials were evaluated 
microscopically. Data were collected and 
analyzed by Kruskal-Wallis and the Tukey tests, 
a value of P<0.05 was deemed significant.
RESULTS
On the first day, light microscopy showed that 
osteoblasts adjacent to gray and white MTA show
good attachment and morphological spread. 
Adjacent to IRM, all the cells were round and 
separated from the plate surface.
After three days cellular morphology adjacent to 
gray and white MTA show expansion and surface 
attachment demonstrating suitable tissue 
compatibility. Cells contacting with IRM seemed 
completely round and inactive.
After seven days microscopic view of the cells 
adjacent to white and gray MTA demonstrated
active and vital osteoblasts confirming tissue 
compatibility (Figures1A, 1B), but cells adjacent 
to IRM were still round and inactive (Figure 1C).
In the evaluation of IL-1b secretion the Kruskal-
Wallis test demonstrated that there were no 
significant differences in the mean levels of IL-
1 secretion at different time intervals adjacent 
to each material (P>0.05). Kolmogorov-
Smirnov test confirmed normal distribution of 
the data. The results are shown in Table 1 and 
Figure 2. Tukey test was used to compare the 
average levels of IL-1 secreted by the 
osteoblasts. There was no significant difference 
in the mean secretion level of IL-1 in presence 
of gray MTA and white MTA (P>0.05). 
However, the average amount of IL-1 in 
MTAs’ groups were significantly higher than 
IRM group (P<0.05).
DISCUSSION
Reinforced zinc oxide and eugenol cements 
such as IRM and Super EBA are the most 
commonly used root-end filling materials 
(13,14). Previously, IRM has been widely used 
in root-end fillings and perforation repairs; 
however the toxicity of this material is proven. 
Accordingly, authors e.g. Koh et al. used IRM 
in their studies as the negative control (21). 
Holland et al. showed that both gray and white 
MTA were biocompatible when implanted in rat 
connective tissues (22,23). Oviir et al. showed 
that cementoblasts grow significantly better on 
the surface of white MTA (24). In contrast, 
Pérez et al. showed that white MTA was not as 
biocompatible as the gray type (17). Different 
studies have shown that osteoblasts adjacent to 
this material morphologically alter and turn into 
round cells, indicating cytotoxicity (21).
Cell culture experiments are the method of 
choice for biocompatibility studies because they 
are simple, rapid, and cheap compared to other 
methods. A review recently declared that the 
two most commonly used methods for
biocompatibility are SEM and enzyme assays
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         Table 1. IL-1 levels (mean±SD) secreted by human osteoblasts (Pico gram/milliliter) adjacent to different test materials
Material Day 1 Day 3 Day 7 Mean P-value
Gray MTA 19.2±2.3 15.68±3.34 14.57±3.8 16.57
P>0.05White MTA 15.85±0.92 14.76±1.8 16.03±3.4 15.59
IRM 1.93±0.61 2.73±1.1 3.32±0.55 2.73
(25). The main issue with SEM in cell culture 
studies was material’s reaction to preparation 
media. Enzyme assay was more reliable as it 
evades materials reactions (25). 
Our study showed good IL-1 expression for 
both forms of MTA. The amount of IL-1
secreted by MG-63 osteoblasts adjacent to gray 
MTA and white MTA was significantly higher 
than that secreted by osteoblasts adjacent to IRM. 
There was no significant difference in the amount 
of IL-1 adjacent to gray MTA and white MTA.
MTA is known to cause an increase in IL-4 and 
IL-10 expression (26). Increase in IL-6 and IL-
8, with no increase in level of IL-1α and IL-1β 
was demonstrated in the presence of MTA (27). 
Koh et al. showed a rise of both IL-1α and IL-
1β together with IL-6 after the cells were in 
contact with the material for 6 days (21). They 
also showed no increase in cytokine release 
adjacent to IRM. MTA is also known to 
preferably induce alkaline phosphates expression 
and activity in fibroblasts of periodontal ligament 
and gingival cells (28).
In general, MTA elicited an inflammatory 
cytokine response. In contrast, no cytokine 
productionwasobservedinone odd study, where 
the lack of cytokines was accompanied by cell 
lysis and protein denaturating around MTA (18). 
There is substantial evidence indicating the 
important role of cytokines in pulp and 
periapical diseases. The key cytokine involved 
in inflammatory pulp and periapical reactions is 
IL-1, secreted by a wide variety of cells. It is 
believed that all of the cells found in pulp and 
periapical lesions are capable of producing and 
secreting IL-1 (29). However, the most 
important cells that secrete IL-1 are monocytes, 
macrophages, endothelial cells, osteoclasts, 
osteoblasts, fibroblasts and PMNs (29).
IL-1, IL-1 and tumor necrosis factor-alpha 
(TNF-) promote bone destruction by osteoclasts. 
In humans, IL-1 has an OAF (osteoclast 
activating factor) role, indicating its high level of 
expression and its pharmacologic potential (30).
It has also been demonstrated that IL-1 has an 
important role in acute inflammation.
On the other hand, it has been demonstrated 
that IL-1 has positive and negative roles in the 
repair process. It has also been found that 
proinflammatory cytokines have an important 
role in pulp protection by preventing the spread 
of infection (29). It is believed that large group 
of mediators such as Bone Morphologic 
Proteins (BMPs), Epidermal Growth Factor 
(EGF), IL-1 and IL-6 can accelerate 
infiltration, proliferation and differentiation of 
progenitor cells into osteoblasts (29).
Koh et al. compared the cytokines’ levels (IL-
1, IL-1andIL-6)secretedbyMG-63osteoblasts 
adjacent to MTA and polymethylmethacrylate 
(PMA), the commonly used orthopedic cement. 
They demonstrated an increase in the secretory 
levels of these cytokines adjacent to gray MTA 
during the first 48 hours but the cells adjacent to 
PMA did not reveal any increase in the secretory 
levels of these cytokines (30).
The increase in the level of IL-1 in MTA 
containing specimens may demonstrate the 
activation of osteoblasts adjacent to gray MTA 
and white MTA.
CONCLUSION
Human osteoblasts responded more actively 
adjacent to white and gray mineral trioxide 
aggregate compared to Intermediate Restorative 
Material, indicating the biocompatibility of these 
two materials.
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